COMMUNIQUÉS West-GlobeNewswire

Establishment Labs to Present at UBS Global Healthcare Conference
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
26/04/2019
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company [...]
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
26/04/2019
Proposed acquisition establishes a key franchise for Repligen in the rapidly growing Process Analytics segment of bioprocessing Adds a market leader in protein concentration measurement with proprietary and [...]
Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer
26/04/2019
Investor News Hørsholm, Denmark and Cambridge, MA, US, April 26, 2019 – Oncology Venture A/S announced today that an editorial published in Pharmagenomics explains how the DRP ® can guide the treatment for breast cancer [...]
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
26/04/2019
OXNARD, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, has been named 2019’s Innovative Business of the Year by Oxnard Chamber [...]
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test
26/04/2019
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst ® -Lung liquid biopsy test InVisionFirst ® -Lung demonstrated excellent concordance with tissue profiling and detected [...]
miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru
26/04/2019
Continued evidence of disease stabilization observed in ATLL patients treated with cobomarsen for up to 16 months Cobomarsen allowed for rapid bone marrow recovery following chemotherapy In most patients, biomarkers [...]
111 to Announce First Quarter 2019 Unaudited Financial Results on May 16, 2019
26/04/2019
SHANGHAI, China, April 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its [...]
Annual Report 2018 Active Biotech AB (publ)
26/04/2019
PRESS RELEASE Active Biotech's Annual Report 2018 is now available for download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. [...]
Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes
26/04/2019
Bagsværd, Denmark, 26 April 2019 - Novo Nordisk today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like peptide-1 (GLP-1 [...]
Vistin Pharma ASA: Annual Report 2018
26/04/2019
Oslo, 26 April 2019 Please find attached the Annual Report for 2018 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 19 February [...]
C-RAD and OPASCA announce strategic partnership
26/04/2019
C-RAD, providing cutting-edge solutions ensuring exceptionally high precision, safety and efficiency in advanced radiation therapy, and OPASCA, the leader in innovative patient safety and workflow management solutions [...]
Notice of annual shareholders’ meeting in Saniona AB
26/04/2019
PRESS RELEASE April 26, 2019 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona [...]
Motif Bio plc: Notice of Annual General Meeting
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc ("Motif Bio" or the "Company") (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that [...]
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote “FOR” Proposed Acquisition by Biogen
26/04/2019
WALTHAM, Mass. and LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc ("Nightstar") (NASDAQ: NITE) today announced that both leading independent proxy advisory firms, Institutional Shareholder [...]
Motif Bio Announces Appointment of Andrew Powell to Board of Directors
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced the [...]
The Nomination Committee of Saniona Proposes Election of One Additional Member of the Board of Directors
26/04/2019
PRESS RELEASE April 26, 2019 Saniona (OMX: SANION), a biotech company focused on the treatment of eating disorders and diseases of the central nervous system, announced today that its Nomination Committee comprised of [...]
SuperSonic Imagine will present its new Aixplorer MACH 30 at the 62nd Society for Pediatric Radiology Annual Meeting
26/04/2019
April 30 to May 4 in San Francisco, California AIX-EN-PROVENCE, France, April 26, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in ultrasound medical imaging ( [...]
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
26/04/2019
Paris, April 26, 2019 Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER Q1 2019 Change Change at CER IFRS net sales reported €8,391m +6.2% +4.2% IFRS net income reported €1,137m +11.9% - IFRS EPS [...]

Pages